General Information
Revision date
2016-06-20
Product name
ILARI LYVI 150MG (X) AU
Product Synonyms
Canakinumab
CAS No.
914613-48-2
Icons in SDS
Company Information
company name
Novartis Pharma AG
e-mail address of the competent person responsible for the Safety Data Sheet
sds.support@novartis.com
Section 2
SECTION 2: Hazards identification
For side effects, which could also have impact for people working with this substance, please refer to the Patient Information Leaflet.